Few biotech companies venture into diagnostics, largely because they believe that therapeutics and diagnostics don’t mix. However, a handful of biotech/ small pharmaceutical companies are active in diagnostics and therapeutics, taking largely one of two approaches: using diagnostics to obtain near-term cash flow or as an integral part of a broader strategy in disease management.